 |
|
To slow AIDS in Russia, treat HIV-positive addicts, Stanford study says
November 10, 2006STANFORD, Calif.-The key to combating AIDS in Russia may be to treat HIV-infected drug users. A new model estimating the spread of HIV in Russia suggests that treating injection drug users with antiretroviral medication will slow transmission of the virus among the general population.
The study, which will appear in the December issue of the journal AIDS, was led by Douglas Owens, MD, a researcher at the Veterans Affairs Palo Alto Health Care System and professor of medicine at the Stanford University School of Medicine, and Margaret Brandeau, PhD, professor of engineering at Stanford.
Estimates vary, but around 1 million Russians-slightly more than 1 percent of the adult population-are infected with HIV, the virus that causes AIDS. Injection drug users account for three-quarters of all HIV cases in Russia, and the epidemic is spreading rapidly to non-drug users. According to the United Nations, Russia's HIV infection rate is among the fastest-growing in the world. By 2020, HIV could afflict 14.5 million Russians, according to a study from the Woodrow Wilson Center in Washington, D.C.
Advances in antiretroviral therapies have the potential to stem the spread of the virus in Russia, but in 2005 less than 1 percent of HIV-infected Russians-5,000 people-received the life-extending drugs.
The situation is worse among drug users. "Almost no injection drug users in Russia are getting antiretroviral drug therapy," said Owens.
Antiretroviral therapies now combine multiple individual drugs to reduce the amount of virus in a person's body. The cumulative effect of two or three medicines works better than a single one to keep the virus at bay. Antiretroviral therapies have the added benefit of reducing the chances that an infected person will transmit HIV to others.
To understand how antiretroviral therapy could affect HIV transmission in Russia, Owens and Brandeau, along with doctoral student Elisa Long, created a computer model of the virus' spread through the adult population in St. Petersburg, Russia. They accounted for infection rates among drug users and non-drug users and the reduced viral transmissibility and increased life expectancy of infected individuals on antiretroviral medication.
The researchers examined the hypothetical impact of treating only non-drug users, treating only addicts, treating both groups or maintaining the status quo. Owens called the approach a "thought experiment," designed to predict how treating different groups in the population would affect the overall epidemic.
"Exclusively treating non-drug users is not a wise approach. It's the least efficient and it's the least effective," said Long.
According to the model, treating only HIV-infected drug users will prevent more infections among non-drug users than exclusively targeting the non-drug users. Injection drug users are likely to spread HIV through unprotected sex, so reducing their ability to spread the virus can significantly reduce the spread of HIV to the general population.
The researchers also looked at the expense of the various treatment strategies, which had an estimated cost between $9.4 and $11.2 billion over 20 years. Giving medication only to non-drug users was not the most expensive approach, but it prevented the fewest new infections, according to the study. Treating both populations equally provided the most health benefit for the money, said Owens.
One key to implementing treatment programs will be keeping injection drug users on their HIV medications, said Owens. Antiretroviral therapy regimens have become much simpler, often requiring patients to take just one or two pills per day.
"If they can get the treatment and support, intravenous drug users can do well taking their medications," said Owens.
The study has important implications for Russia's approach to combating AIDS. Antiretroviral therapy is expanding in Russia, but it remains to be seen whether drug addicts will receive treatment, Owens said. "Our main message is that really to have an impact on the epidemic, you have to treat both the drug users and non-drug users."
Stanford University Medical Center
Advances in antiretroviral therapies have the potential to stem the spread of the virus in Russia, but in 2005 less than 1 percent of HIV-infected Russians-5,000 people-received the life-extending drugs.
The situation is worse among drug users. "Almost no injection drug users in Russia are getting antiretroviral drug therapy," said Owens.
Antiretroviral therapies now combine multiple individual drugs to reduce the amount of virus in a person's body. The cumulative effect of two or three medicines works better than a single one to keep the virus at bay. Antiretroviral therapies have the added benefit of reducing the chances that an infected person will transmit HIV to others.
To understand how antiretroviral therapy could affect HIV transmission in Russia, Owens and Brandeau, along with doctoral student Elisa Long, created a computer model of the virus' spread through the adult population in St. Petersburg, Russia. They accounted for infection rates among drug users and non-drug users and the reduced viral transmissibility and increased life expectancy of infected individuals on antiretroviral medication.
The researchers examined the hypothetical impact of treating only non-drug users, treating only addicts, treating both groups or maintaining the status quo. Owens called the approach a "thought experiment," designed to predict how treating different groups in the population would affect the overall epidemic.
"Exclusively treating non-drug users is not a wise approach. It's the least efficient and it's the least effective," said Long.
According to the model, treating only HIV-infected drug users will prevent more infections among non-drug users than exclusively targeting the non-drug users. Injection drug users are likely to spread HIV through unprotected sex, so reducing their ability to spread the virus can significantly reduce the spread of HIV to the general population.
The researchers also looked at the expense of the various treatment strategies, which had an estimated cost between $9.4 and $11.2 billion over 20 years. Giving medication only to non-drug users was not the most expensive approach, but it prevented the fewest new infections, according to the study. Treating both populations equally provided the most health benefit for the money, said Owens.
One key to implementing treatment programs will be keeping injection drug users on their HIV medications, said Owens. Antiretroviral therapy regimens have become much simpler, often requiring patients to take just one or two pills per day.
"If they can get the treatment and support, intravenous drug users can do well taking their medications," said Owens.
The study has important implications for Russia's approach to combating AIDS. Antiretroviral therapy is expanding in Russia, but it remains to be seen whether drug addicts will receive treatment, Owens said. "Our main message is that really to have an impact on the epidemic, you have to treat both the drug users and non-drug users."
Stanford University Medical Center
Wound botulism
In a case study in PLoS Medicine, doctors report on the case of a 35 year old heroin user who came to the accident and emergency department with double vision, slurred speech, drooping eyelids, and eye muscle weakness. The diagnosis turned out to be wound botulism.
Medical Whistleblowers Speak Out
FDA official says agency was "single greatest obstacle to doing anything effective" about Vioxx The US Food and Drug Administration (FDA) was "the single greatest obstacle to doing anything effective" about Vioxx, said FDA drug safety officer David Graham at an unprecedented roundtable of medical whistleblowers sponsored by the international Public Library of Science (PLoS) and the Government Accountability Project. In comments that echoed his now infamous testimony to the US Senate Finance Committee, Graham said that, "Nearly 60,000 people probably died from that drug. That's as many of our soldiers that were killed in the Vietnam war [who] died as a result of Vi
Drug users unaware of memory problems
Ecstasy and cannabis do impair memory - but regular users don't think so.
More Drug User News Articles
| Drug Calculations Online for Calculate with Confidence (User Guide, Access Code and Textbook Package) by Deborah C. Gray Morris, Carmen Adams This convenient, money-saving package is a must-have for students training for a career in nursing. It includes the Gray Morris: Calculate with Confidence, 4e textbook and Drug Calculations Online. For further information on each individual product, please click on the link provided below.Each module is organized by topic and includes an overview, objectives, a reading assignment, example... | |
| Drug Calculations Online for Kee/Marshall: Clinical Calculations: With Applications to General and Specialty Areas (User Guide, Access Code and Textbook Package) by Joyce LeFever Kee, Sally M. Marshall, Susan Turner, Donna Eberly This convenient, money-saving package is a must-have for nursing students! It includes Clinical Calculations, 6th edition and Drug Calculations Online for Clinical Calculations, 6th... | |
| Drug Calculations Online for Ogden Calculation of Drug Dosages (User Guide, Access Code and Textbook Package) by Sheila J. Ogden, Linda Fluharty, Angela Koller This convenient, money-saving package is a must-have for LPN nursing students! It includes Ogden Calculation of Drug Dosages, 7th edition text and Ogden's Drug Calculations Online, 7th... | |
 | The Criminal Personality : The Drug User - Vol.3 by Stanton Samenow Yochelson and Samenow attribute crime to a series of early irresponsible choices that predate drug use among drug-using criminals. Personality and personal choice variables are conceptualized as critical in initialing and maintaining use. In what is called an indiscriminate search for excitement, drug-using criminals are characterized as expanding their criminal repertoire while excusing their... |
 | The Heroin User's Handbook by Francis, Ph.D. Moraes |
| Coke: Close Up The Drug the Dealers the Users by MARC OLDEN | |
| MyNursingPDA: Pediatric Drugs & Nursing Implications Individual User Access Code (MyNursingPDA Series) by Ruth Bindler, Linda Berner Howry, Billie Ann Wilson, Margaret T. Shannon, Carolyn L. Stang | |
| Drug Calculations Online To Accompany Math For Clinical Practice : User Guide, Access Code And Textbook Package by Denise/ Adams, Carmen Macklin This online drug calculations course consists of 7 modules corresponding to the parent text, Macklin's Math for Clinical Practice. Through the online Evolve course management system, this learning tool serves as a complete drug calculations program to teach and reinforce good math skills. Because each module works with the textbook, students can read chapter content and then apply and practice... | |
| Drug Calculations Online for Clinical Calculations - Text (Revised Reprint), User Guide and Access Code Package by Joyce LeFever Kee, Sally M. Marshall This convenient, money-saving package is a must-have for students training for a career in nursing. It includes the Kee: Clinical Calculations, 5e Revised Reprint textbook and Drug Calculations Online. For further information on each individual product, please click on the link provided... | |
 | The Truth About Pot: Ten recovering Marijuana Users Share Their Personal Stories by Joanne Baum Marijuana use has increased over the past four years and now accounts for over 81 percent of this nation's illicit drug use. It is widely considered not only to be harmless to its users but also to have the power to enhance concentration and creativity, to relieve pain and suffering, and to offer a much needed respite from the hectic pace of today's world. It's no wonder that marijuana is... |
| © 2008 BrightSurf.com |